FDA Inspection
Hybrid Pharma LLCHybrid Pharma LLC – FDA Inspection, Jul 28, 2016
Record Details
This FDA Inspection record concerns Hybrid Pharma LLC, with an inspection on July 28, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Hybrid Pharma LLC
- Inspection Date
- July 28, 2016
- Product Type
- Drugs
View Company Profile
ID · 579d186a-aadb-4bb3-82f9-da4baf9e8455
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 983055
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
9- 21 CFR 211.42(c)(10)(v)Cleaning System
- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
- 21 CFR 211.28(a)Clothing appropriate for duties performed
- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
- 21 CFR 211.165(e)Test methods
- Drug product label, outsourcer facility
- 21 CFR 211.166(a)Lack of written stability program
- 21 CFR 211.192Written record of investigation incomplete
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Hybrid Pharma LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| November 9, 2023 | OAI | Drug Quality Assurance | |
| September 3, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 20, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hybrid Pharma LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.